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ABSTRACT
Objective: The study was aimed to evaluate glucose homeostatic and pancreas protective potential of Tecomella undulata root extract in streptozotocin 
induced diabetic rats.
Methods: The ethanolic root extract was prepared by following standard soxhlation methods. The experimental design was divided in to control and 
treated groups for 28 days of comparative experimental schedule. The body and organ weights, serum biochemistry, histo-pathology, hematology and 
toxicity profiles were assayed by following standard methods and protocols. 
Results: The treatment of ethanolic extract of root of T. undulata was significantly (p ≤ 0.001) reduced glucose levels at 7day, 14day, 21day and 28 days 
in comparison to standard drug of metformin. Correspondingly, lipid profile i.e. total cholesterol, HDL, VLDL, LDL and triglyceride were also altered 
significantly. Whereas, body and organs weight and hematological parameters were not shown significant changes. Subsequently, toxicity profile 
i.e. hepatic and renal parameters were remained under normal ranges. Corresponding, the treatment of ethanolic root extract caused normalcy of 
histoarchitecture of pancreas in comparison to standard drugs. 
Conclusion: The results of study illustrated that Tecomella undulata root extract possessing particular kind of phytocompounds which caused glucose 
homeostatic and pancreas protective potential in diabetic rats.
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INTRODUCTION
Diabetes is an endocrine, metabolic disease which is clinically 
characterized by chronic hyperglycemia due to poor insulin availability. 
The etiology of diabetes can be inducing pathological damage to the 
liver, kidneys, and pancreas, with characteristic abnormalities in the 
metabolism of carbohydrates, lipids, and proteins [1-3]. Whereas there 
are several kinds of therapeutic approaches for diabetes, but associated 
side effects pointed out to rethink. Behind this, the ancient Indian 
medical system of the Ayurveda having peculiar kind of therapeutic 
patterns which shown minimum drug-associated side effects those 
are mainly based on herbal formulation. Herbal formulations have 
been existed worldwide with long documented history and used 
in various civilizations, i.e., ancient Chinese, Greek, Egyptian, and 
Indian for several remedies determinations [4-11]. The World Health 
Organization estimated that 80% of the word’s populations still depend 
on traditional medicines for their health problems. Whereas the Indian 
subcontinent is a renowned to be one of the major biodiversity center 
with about 45,000 plant varieties. In India, about 15,000 medicinal 
floras have been noted, and up to 7,000-7,500 plants are used by 
communities for therapeutics of various kinds of ailments [11,12].
In similar kind of view, western Rajasthan (Part of the Thar desert) 
having peculiar kind of medicinal plants which are used by local 
people from long back based on conventional wisdom for therapeutics 
of diabetes and other diseases [5,12,13]. The local desert plants 
having a huge and unique number of secondary metabolites and 
phytocompounds through the specific stress conditions of desert. Even 
Rajasthan state having their own state flower, i.e., Tecomella undulate is 
rich source of numerous valued bioactive phytocompounds. Whereas, 
the various parts of T. undulata are also used for various ailments. The 
root and bark possessing some peculiar kinds of phytocompounds, 
i.e., radermachol, lapachol, tecomaquinone-I, α-lapachone, β-lapachone, 
stigmasterol, β-sitosterol, oleanolic acid, ursolic acid, and betulinic 
acid which are prescribing in the Ayurveda practices and available in 
market [14,15]. The various parts of T. undulate have also been used in 
the curing of syphilis, painful swellings, antibacterial, hepatoprotective, 
immunomodulatory, and anti-inflammatory activities [16-20]. However, 
the root of this plant is main part which directly exposed to climatic 
stress conditions having an abundance of bioactive phytocompounds. 
Therefore, this effort was made to assess glucose homeostatic, and 
pancreas-protective potential of ethanolic root extract of Tecomella 
undulate through investigations of body and organs weights, serum 
biochemistry, histopathology of pancreas and hematology.
METHODS
Chemicals
Required chemicals and reagents were obtained from local Loba chemie 
suppliers, and test kits (Erba) were also used for biochemical analyses.
Collection and extraction of chosen plant material
The roots parts of T. undulata were collected from in and around 
university new campus which were authenticated by taxonomist of 
botany, department of botany.
The dried root was grinded and soxhalated in 70% ethanol for 18 hrs 
at 72°C temperature. The prepared extract was dried and used as per 
routine protocol [21].
Dose of extract and drug
The dose regime of extract and drug were allocated for oral 
administration, i.e., 500 mg/kg body weight for 28 days in comparison 
to metformin at the dose of 100 mg/kg/d.
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Experimental animal
Adult albino rats (Rattus norvegicus) weighing of 170-250 g were 
obtained from the animal house of Indian Veterinary Research Institute, 
Briley, UP. The animals were kept under standard environmental 
situations, i.e., 12 hrs. light and dark cycles with optimal temperature 
conditions of 24-28°C. The feeding and diet were maintained as 
per recommendations of the Veterinarian advice with the proper 
proportion of nutrients and vitamins along with a supply of drinking 
water ad libitum. While animal experimental protocols were permitted 
by Institutional Animal Ethical Committee (Reg. No: 1646/GO/
ERe/S/12/CPCSEA).
Diabetes induction
The induction diabetes by following our laboratory protocol as single 
IP inoculation of streptozotocin (STZ) (Sigma-Aldrich, Mumbai, India) 
dissolved in 0.01 M sodium citrate buffer (pH 4.5), and managed at a 
dose of 55 mg/kg in overnight fasted animals [22].
Experimental design
Diabetic animals were subjectively arranged into four groups and 
an individual group consisting of seven animals to control and 
experimental groups for respective treatment for 28 days.
• Group 1: Vehicle control.
• Group 2: Diabetic control.
• Group 3: Diabetic + T. undulate root extract (500 mg/kg b.w.) for 
28 days.
• Group 4: Diabetic + metformin (100 mg/kg/d) for 28 days.
Serum biochemistry assessments
The glucose variations at different days, related lipid profile (triglyceride, 
total cholesterol, high-density-lipoprotein-cholesterol, low-density 
lipoprotein [LDL]-cholesterol, very LDL [VLDL] – cholesterol, and 
other indices) and toxicology profile, i.e., urea, uric acid, creatinine, 
serum glutamic oxaloacetic transaminase (SGOT), serum glutamate-
pyruvate transaminase (SGPT), alkaline phosphatase, bilirubin, total 
protein, albumin, and globulin were evaluated from serum using 
commercial supplied biological Erba kits (glucose oxidase-peroxidase 
methods) [23-25].
Hematological analysis
Red blood corpuscle (RBC) counts, hemoglobin content, total leukocyte 
cells, platelets (thrombocytes) count, and other related parameters of 
hematology were calculated by standard methods [26].
Histopathological investigations
The histopathology specimens of the pancreas were made by following 
standard protocol of our laboratory. The paraffin sections were stained 
by hematoxylin-eosin and microphotography made by camera attached 
microscope to study pancreas-protective changes in histoarchitectures 
of pancreas in control and treated animals [27-29].
Statistical analysis
All values of biochemistry, hematology, body and organs weights were 
evaluated by one-way ANOVA, followed through Dunnett test using 
software Sigma-Sat trial version. In all the tests, the criteria of statistical 
significance were p≤0.005.
RESULTS
The treatment of root extract of T. undulata caused significant 
alterations in treated experimental groups in comparison to metformin 
treatment and diabetic control as shown in following results.
Body and organs weights
The root extract of T. undulate showed a non-significant reduction in 
body weight, pancreas, and liver. Whereas other morphological signs 
were shown fatigue and less activeness in diabetic rats in comparison 
to treated and vehicle control (Table 1).
Serum biochemistry
a. The treatment of root extract of T. undulata revealed significant 
(p≤0.001) gradual decreases in glucose levels in comparison to 
metformin at 7 days, 14 days, 21 days, and 28 days with diverse 
grades. However, significant raised glucose level was observed in 
diabetic rats up to 250-350 mg/dl (Fig. 1).
b. Accordingly, the lipid profile, i.e., total cholesterol, LDL- cholesterol, 
triglyceride, and VLDL-cholesterol were significantly (p≤0.001) 
decreased in treated animals as a comparison to diabetic control 
(Table 2).
c. Compassionately, toxicity profile, i.e., creatinine, urea, uric acid, SGOT, 
SGPT, alkaline phosphatase, bilirubin total protein, albumin, and 
globulin were endured under and around normal ranges (Fig. 2).
Haematology
RBC count, total leukocytes count, platelets count, and other related 
morphological parameters were not altered significantly in treated 
groups (Fig. 3).
Histopathology
The pancreatic histoarchitecture of vehicle control consisting of 
condensed, lobulated compounds of tubuloacinar gland of exocrine and 
endocrine part with distinguished symmetry. The islets, i.e., endocrine 
part exhibiting of diverse sizes and surrounded inside the exocrine 
tissue of pancreas with bright staining. There were three diverse 
categories of islets seen, i.e., small, medium, and large sized were 
distinguished. Individually, islet was consisting of alpha, beta, delta, and 
pancreatic polypeptide cells embedded in peripheral tissues of acini 
and vessels (Fig. 4). Whereas, diabetic pancreatic histology showed 
vacuolization and deterioration in islet cells with congestion of RBC. 
The diabetic pancreas correspondingly exhibited indiscretions in 
peripheral exocrine parts and vascular part (Fig. 5).
However, the treatment of root extract of T. undulate encouraged re-
architecture of islet as well as the reorganization of peripheral tissues 
(Fig. 6). Correspondingly, the treatment of metformin revealed near 
to normalcy of islet with existing of cells and proper arrangement of 
peripheral tissues (Fig. 7).
DISCUSSION
Hyperglycemia and non-functional pancreatic β-cell are considered 
as a diabetic pathological condition from primary description [30,31]. 
Whereas there are several kinds of pharmacological approaches for 
Table 1: Effect on body and organs weight of root extract of T. undulata in STZ‑induced diabetic albino rats (mean of 5 values SEM)
Group Mean body weight (gm) Heart Pancreas Kidney Liver
Initial Final mg/100gm body weight g/100 g body weight
Group I (vehicle control) 203.13±3.13 209.23±7.17 469.12±07.33 231.21±21.17 581.09±31.11 4.93±0.31
Group II (diabetic control) 199.11±7.01 193.11±10.02c 453.17±13.11d 178.17±31.10c 511.31±22.07d 4.13±0.23c
Group III (T. undulata root 
extract treatment)
210.01±9.11 201.12±7.11d,h 467.21±11.23d,h 203.21±17.11c,g 563.33±31.11d,h 4.41±0.11d,h
Group IV (metformin 
treatment)
211.7±7.01 203.01±9.21d,h 471.70±19.01d,h 201.19±19.13c,g 577.23±17.31d,h 4.89d,h±0.21d,h
Data are means±SEM. (n=7), cp≤0.001, dnon-significant as compared to the respective control values, gp≤0.001, and hnon-significant as compared to the respective values 
of the diabetic control group, T. undulate: Tecomella undulate, STZ: Streptozotocin
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Fig. 2: Effect of Tecomella undulate root extract on renal and liver function indices in streptozotocin induced diabetic albino rats. Data 
are Mean±standard error mean. (n=7); cp≤0.001, d non-significant as compared to the respective control values, gp≤0.001, and hnon‑
significant as compared to the respective values of the diabetic control group
caring diabetes and other diseases, but issues of side effects are still 
questionable. Although natural cures were used and still be used 
today with minimum side effects. There are many herbs with strong 
antidiabetic properties by following different mechanisms [32-37]. In 
the present study, the treatments of root extract of T. undulata performed 
hypoglycemic effect in gradual reductions in comparison to metformin 
Fig. 1: Effect of Tecomella undulate root extract on glucose levels in streptozotocin induced diabetic albino rats. Data are Mean±standard 
error mean SEM (n=7), cp≤0.001, dnon‑significant as compared to the respective control values, gp≤0.001, and hnon‑significant as 
compared to the respective values of the diabetic control group
Table 2: Effect of T. undulata root extracts on lipid profile in STZ induced diabetic albino rats
Groups Cholesterol HDL (mg/dl) LDL (mg/dl) VLDL (mg/dl) Triglyceride (mg/dl) LDL/HDL
Group I (vehicle control) 106.01±7.23 30.11±2.10 52.29±3.16 23.61±1.96 118.03±09.31 1.74±0.02
Group II (diabetic control) 235.61±12.12c 29.89±2.23d 167.92±6.12d 37.80±3.16d 189.01±6.67a 5.62±0.32c
Group III (T. undulata root 
extract treatment)
126.58±09.73c,g 30.71±0.32d,h 73.33±0.59c,g 22.54±0.23c,h 112.7±0.62c,f 2.29±0.03c,h
Group IV (metformin 
treatment)
127.44±5.11c,f 30.17±0.63d,h 75.39±0.32c,f 22.08±1.07c,h 110.41±1.7c,f 2.57±0.17c,h
Data are means±SEM. (n=7), cp≤0.001, dnon-significant as compared to the respective control values, gp≤0.001, and hnon-significant as compared to the respective values 
of the diabetic control group, T. undulate: Tecomella undulate, STZ: Streptozotocin, LDL: Low-density lipoprotein, HDL: High-density lipoprotein, VLDL: Very low-density 
lipoprotein, ap≤0.05, fp≤0.01 
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standard drug [13,20,38]. This type of activity may be conducted 
through alone or synchronic action of possessing bioactive compounds, 
i.e., oleanolic acid, ursolic acid, betulinic acid, triacontanol, cirsimaritin, 
cirilineol, pentariacontanol, 4,5-dihydroxy 3,6,8- trimethoxyflavones, 
and other phytocompounds as described by earlier researchers. The 
treatment caused non-significant and significant changes in body and 
organs weights. The changes in body and organs weights could be 
following STZ activities and ameliorative actions of phytocompounds 
against hyperglycemia correspondingly [35,39].
However, there are stated some hypothesis regarding hypoglycemic 
or insulin mimic effect of plant products as their effects on the 
activity of pancreatic beta cells, increase in the oppressive action 
against insulinase enzyme, establishment of the insulin sensitivity 
or the insulin-like effect of the phytocompounds and through other 
mechanisms [40]. However, other concept suggested that it might also 
be involved such as increase of peripheral consumption of glucose, 
intensification of synthesis of hepatic glycogen or reduction of 
glycogenolysis, inhibition of intestinal glucose absorption, decrease of 
glycemic index of glycemic content, and decrease of the consequence of 
glutathione. In parallel milieu, lipid parameters, i.e., total cholesterol, 
LDL -cholesterol, triglyceride, and other indices were also reduced 
which may be due to be lacking in changes of gluconeogenesis and 
unapproachability of peripheral excess glucose [41,42]. Subsequently, 
the STZ caused a substantial reduction in pancreatic cells and structural 
fluctuations as stated by some studies [1,16,42]. The introduction 
of STZ caused β-cell toxicity is rational through carboxylation of 
proteins, alkylation of DNA, release of free radicals (reactive oxygen 
species and reactive nitrogen species) and inhibition of O-GlcNAcse 
(glycoside hydrolase). These types of detrimental actions made by STZ 
are accountable for necrosis of pancreatic β-cells and introduction of 
experimental diabetes mellitus in laboratory animal models. Although 
the treatments of root extract of T. undulata caused various grades 
of a renaissance in pancreatic cells and endorsing numerous grade 
of re-histoarchitecture of pancreas. This kind of action of herbal 
products also stated by previous studies and illustrations that having 
bioactive compounds might consume congested more devastation of 
the enduring β-cells in the islet by mopping up the circulating reactive 
oxygen species generated through the STZ to devastate the β-cells and 
then permitting additional phytochemicals of the herbal to stimulate 
regenerative activities [1,43]. The administration of the herbal 
extract todiabetic animals provoked a decrease in aminotransferases 
in serum, i.e., SGOT, SGPT, and alkaline phosphatase, a result of 
experimental and toxicological importance quantified that changes in 
their actions are pinpointing of tissue impairment by contaminants or 
signs resultant to hepatic disorders. This declination of SGPT, SGOT, 
and alkaline phosphatase to their normal levels might be chosen by 
the absence of alkanes in the extract [43]. Correspondingly, other 
renal and hepatic parameters were also come to under or around 
regular ranges which suggested nontoxic nature of T. undulata 
extract. Compassionately, hematological parameters were also 
persisted under normal ranges which also proven least toxic nature 
of possessing phytocompounds [24,26,44]. Therefore, it is concluded 
that phytocompounds possessing in root extract of T. undulate having 
potential of glucose homeostatic and pancreatic protection which can 
be help in therapeutic strategies of diabetes.
Fig. 3: Haematological assessments of Tecomella undulate root extract treatments in streptozotocin induced diabetic albino rats (mean of 
5 value±standard error mean [SEM]). Data are means±SEM. (n=7), cp≤0.001, dnon‑significant as compared to the respective control values, 
gp≤0.001, and hnon‑significant as compared to the respective values of the diabetic control group
Fig. 4: Pancreatic histoarchitecture of intact vehicle control rats 
(H and E ×200) ‑ the histoarchitecture of intact vehicle control 
pancreas exhibiting of islets of Langerhans with cluster of cells 
organized in asymmetrical departing and anastomosing strings 
detached by blood capillaries and subtle collagen fibres
Fig. 5: Pancreatic histoarchitecture of diabetic control rats 
(H and E ×200) ‑ diabetic pancreatic histoarchitecture containing 
of vacuolated islets of Langerhans and necrotic nuclei of islet cells 
with congested blood vessels
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CONCLUSION
From the finding of this study, it can be concluded that the root extract 
of T. undulata consisting numerous bioactive chemicals, which shows 
a glucose homeostatic and pancreas protective potential. This study 
will be beneficial in additional compounds level can be elaborate more 
utility of this plant product which can verify it as potent cost-effective 
antidiabetic agent from native resources using conventional wisdom.
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